October 8, 2015 Regeneron and Sanofi Announce Publication of Positive Phase 2b Dupilumab Data in The Lancet Study Evaluated Adult Patients with Moderate-to-Severe Atopic Dermatitis who were Inadequately Controlled by To - Atopic dermatitis - Document - PDFSEARCH.IO

First Page	Meta Content
	October 8, 2015 Regeneron and Sanofi Announce Publication of Positive Phase 2b Dupilumab Data in The Lancet Study Evaluated Adult Patients with Moderate-to-Severe Atopic Dermatitis who were Inadequately Controlled by To Add to Reading List Open Document File Size: 17,54 KB Share Result on Facebook

October 8, 2015 Regeneron and Sanofi Announce Publication of Positive Phase 2b Dupilumab Data in The Lancet Study Evaluated Adult Patients with Moderate-to-Severe Atopic Dermatitis who were Inadequately Controlled by ToAdd to Reading List